FERRARA, LIBERATO ALDO
 Distribuzione geografica
Continente #
NA - Nord America 2.738
EU - Europa 1.620
AS - Asia 821
AF - Africa 13
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.204
Nazione #
US - Stati Uniti d'America 2.667
UA - Ucraina 649
SG - Singapore 453
CN - Cina 334
IT - Italia 256
FI - Finlandia 179
DE - Germania 169
IE - Irlanda 120
SE - Svezia 88
GB - Regno Unito 72
NL - Olanda 72
CA - Canada 67
CI - Costa d'Avorio 10
TR - Turchia 9
HK - Hong Kong 8
EC - Ecuador 7
IN - India 6
EU - Europa 5
IR - Iran 5
AT - Austria 4
GT - Guatemala 4
PL - Polonia 3
ES - Italia 2
ID - Indonesia 2
MY - Malesia 2
SL - Sierra Leone 2
CZ - Repubblica Ceca 1
GR - Grecia 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
TN - Tunisia 1
Totale 5.204
Città #
Jacksonville 661
Singapore 356
Chandler 354
Princeton 178
Boston 148
Millbury 128
Wilmington 106
Santa Clara 87
Woodbridge 87
Nanjing 86
Naples 76
Amsterdam 72
Ottawa 66
Houston 55
Beijing 51
Dublin 46
Ann Arbor 38
Boardman 37
Norwalk 28
Ashburn 26
Shenyang 26
Tianjin 24
Hebei 23
Nanchang 20
Napoli 19
Dearborn 18
Jiaxing 17
Changsha 16
Kronberg 12
Des Moines 10
Xi'an 10
Quito 7
Guangzhou 6
Rome 6
Falls Church 5
Casoria 4
Frankfurt am Main 4
Milan 4
Orange 4
Ardabil 3
DesMoines 3
Jinan 3
Kunming 3
Leawood 3
Ningbo 3
Pune 3
Ravenna 3
Stockholm 3
Vienna 3
Acerra 2
Asti 2
Augusta 2
Bari 2
Berlin 2
Bologna 2
Brugherio 2
Cambridge 2
Catania 2
Chandigarh 2
Chengdu 2
Dallas 2
Freetown 2
Hefei 2
Islington 2
Los Angeles 2
Makassar 2
Palermo 2
Parma 2
Pavia 2
Petaling Jaya 2
Polska 2
Pompei 2
Redmond 2
Redwood City 2
Reggio Emilia 2
San Mateo 2
Shenzhen 2
Taizhou 2
Belgrade 1
Brno 1
Central District 1
Changchun 1
Croydon 1
Dalian 1
Davoli 1
Fondarella 1
Fremont 1
Gatteo 1
Hagenberg 1
Hamburg 1
Hangzhou 1
Hanover 1
Helsinki 1
Huizhou 1
Indiana 1
Kingston 1
Lancaster 1
Lanzhou 1
Lecce 1
London 1
Totale 3.031
Nome #
LONG TERM ANTIPLATELET ACTIVITY AND SAFETY OF INDOBUFEN IN PATIENTS WITH CARDIOVASCULAR DISEASE 99
Type of myocardial infarction presentation in patients with chronic kidney disease. 79
Association between post-ischemic forearm blood flow and blood pressure response to maximal exercise in well trained healthy young men 72
Improvement of cardiovascular risk profile in an elderly population of low social level. the ICON (Improving Cardiovascular risk profile in Older Neapolitans) Study 72
Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome 63
Adiponectin gene polymorphism and metabolic syndrome 56
�Metabolic syndrome and vascular reactivity� 55
DASH versus Mediterranean diet in the treatment of hypertensive outpatients 53
Antihypertensive efficacy of the combination of ketanserin + thiazide in hypertensives older than 50 years. 52
Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study 51
Acute and chronic effects of dihydropyridines on triglycerides in humans. 51
Medicina dello sport 50
Low-lipid diet reduces frequency and severity of acute migraine attacks 50
Ambulatory monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension 48
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 47
Effects of different dietary protein intakes on body composition and vascular reactivity. 46
Compendio di Medicina interna 46
Serial speckle tracking and successful post-STEMI percutaneous coronary intervention: incremental value versus visual wall motion analysis. 43
�Dietary pattern and blood pressure control in the Hypertension Outpatient Clinic� 42
Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine 42
Antihypertensive efficacy of the combination of ketanserin + thiazide in hypertensive older than 50 years 42
Left ventricular mass reduction during salt depletion in arterial hypertension. 42
Intra and interobserver variability of renal allograft ultrasound volume and resistive index measurements. 42
Preclinical Systolic Dysfunction In Patients With Stage 3 Chronic Renal Disease 42
Blood pressure at rest, during 24 hour monitoring and in response to sympathetic stimulation in hypertensive patients with metabolic syndrome 41
Analisi ecocardiografica delle variazioni anatomiche e funzionali del ventricolo sinistro in corso di trattamento antiipertensivo con nicardipina 41
Ambulatoy monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension 40
A combination of verapamil captopril and diuretic in the treatment of severe hypertension Cardiovascular Drugs and Therapy 2: 219-220;1988 40
A combination of verapamil, captopril, and diuretic in the treatment of severe hypertension. 40
Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: a controlled study versus placebo 39
Acute and chronic effects of dihydropyridines on triglycerides in humans 39
Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: a controlled study versus placebo. 39
Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered subjects 39
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 39
Complex dietary patterns and blood pressure. 38
Adrenergic system and carbohydrate metabolism. Effects of beta receptor blockade on insulin secretion and peripheral insulin sensitivity in normoglycemic patients 38
Adrenergic blocking agents and lipoprotein lipase activity 38
Ambulatory monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension 38
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 38
CONFRONTO TRA FONOANGIOGRAFIA CON DUPLEX SCAN E PANANGIOGRAFIA TRANSFEMORALE NELLA VALUTAZIONE DELLE VASCULOPATIE CEREBRALI 37
Clinic-daytime blood pressure difference and cardiovascular damage. 37
Response to tilting in hypertensive patients receiving ketanserin. 37
Adrenergic nervous system and left ventricular mass in primary hypertension 36
ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF NICARDIPINE IN NON INSULIN- DEPENDENT DIABETICS WITH HYPERTENSION. THE NIDIM STUDY 36
Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol. 36
Arterial hypertension increases left ventricular mass: role of tight blood pressure control. 35
Cerebrovascular reactivity by transcranial Doppler ultrasonography in insulin-dependent diabetic patients 35
Age related antihypertensive effect of nitrendipine, a new calcium entry blocker agent 35
Calcium antagonists and thiazide diuretics in the treatment of hypertension. 35
HAEMODINAMIC CHANGES IN PERIPHERAL ARTERIAL CIRCULATION DURING ANTIHYPERTENSIVE TREATMENT WITH CAPTOPRIL, METHYLDOPA AND INDAPAMIDE 34
Cardiovascular Phenotype in Sarcopenic Obesity 34
Abnormalities of calcium metabolism in essential hypertension. 34
Lifestyle educational program strongly increases compliance to nonpharmacological intervention in hypertensive patients: a 2-year follow-up study. 34
"Association between blood pressure, dietary salt intake and family history of hypertension: a five year follow-up study" 33
Response to tilting in hypertensive patients receiving ketanserin 33
Ketanserin and hydrochlorothiazide in the treatment of arterial hypertension. 33
Alimentazione, stile di vita e ipertensione arteriosa 33
Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. 32
Association of hyperuricaemia with conventional cardiovascular risk factors in elderly patients 32
The peripheral circulation in the hypertensive patients: effects of antihypertensive drugs 31
Abnormal cholesterol distribution in plasma lipoproteins of male patients with ischemic brain disease. 31
Regional haemodynamics during ketanserin in hypertensive patients 31
"Effects of nicardipine on left ventricular hemodynamic patterns in systemic hypertension" 30
EFFECTS OF β-RECEPTOR BLOCKADE ON CARBOHYDRATE METABOLISM 30
Fattori di rischio relativi all'associazione tra coronariopatia ed insufficienza arteriosa cerebrale 30
Isolated office hypertension and end-organ damage. 30
Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: The Strong Heart Study 30
Long term antihypertensive effect of magnesium supplementation in primary hypertension. 29
Controllo ottimale della ipertensione arteriosa in pazienti con insufficienza cerebrovascolare 29
Cardiovascular abnormalities in never treated hypertensives according to non-dipper statuts American Journal of Hypertension; 11: 1352-1357; 1998 29
MODIFICAZIONI NELLA COMPOSIZIONE DELLE LIPOPROTEINE PLASMATICHE IN CORSO DI TERAPIA ANTIIPERTENSIVA CON DIURETICI TIAZIDICI 29
“Serum cholesterol affects blood pressure regulation” 29
Carotid diameter and blood flow velocities in cerebral circulation in hypertensive patients 29
Long-Term Magnesium Supplementation in Essential Hypertension. 28
Metabolic neutrality in nitrendipine therapy 28
Valutazione con metodica ecodoppler delle lesioni arteriosclerotiche del territorio carotideo extracranico 28
"Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients" 28
Response to sympathetic stimulation and tilting during antihypertensive treatment with nisoldipine 28
[Treatment of hypertension associated with metabolic anomalies]. 28
Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study. 27
Beta-blockers and renal function: observations during treatment with tertatolol 27
Terapia dell'ipertensione arteriosa 27
Effects of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive non-insulin dependent diabetics 27
Accuracy of sonographic volume measurements of kidney transplant 27
Nitrendipine and metabolic balance 26
Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol 26
Progressione e localizzazione dell'arteriosclerosi in un paziente con ipercolesterolemia familiare omozigote 26
Body weight and cardiovascular response to sympathetic stimulation in chilhood 26
EFFECTS OF ALPHA ADRENERGIC AND BETA ADRENERGIC BLOCKADE ON LIPID METABOLISM 26
"Blood pressure and plasma noradrenaline during single high-dose beta-adrenoceptor blockade" 26
"EFFECTS OF SLOW-RELEASE NIFEDIPINE ON LEFT VENTRICULAR MASS AND SYSTOLIC FUNCTION IN MILD OR MODERATE HYPERTENSION" 26
PERIPHERAL CIRCULATION IN HYPERTENSIVE PATIENTS: FINDINGS BY DIGITAL PULSE PLETHYSMOGRAPHY 26
CARDIOVASCULAR EFFECTS OF KETANSERIN, A NEW ANTI-SEROTONERGIC AGENT IN THE TREATMENT OF ARTERIAL HYPERTENSION 26
The effects of nicardipine on sodium and calcium metabolism in hypertensive patients: a chronic study. 26
Combined criteria for prediction of coronary risk in elderly overweight patients 26
Weight reduction lowers blood pressure independently of salt restriction. 26
Olive oil and reduced need for antihypertensive medications. 25
Clinic and ambulatory pulse pressure segregate a cluster of cardiovascular risk factors” 25
Slow-release nifedipine versus placebo in the treatment of arterial hypertension: a double-blind ergometric evaluation of cardiac workload 25
Left ventricular mass and blood pressure during ergometric exercise IN PRIMARY HYPERTENSION 25
Totale 3.695
Categoria #
all - tutte 24.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 0 0 0 132 17 13 4 4 18 58 160
2020/20211.124 2 130 151 131 135 141 132 1 137 8 152 4
2021/2022744 10 0 0 5 2 15 5 39 92 51 194 331
2022/2023871 189 77 11 88 88 85 1 70 161 68 25 8
2023/2024568 16 81 102 19 17 15 6 34 3 4 215 56
2024/2025556 241 212 20 27 56 0 0 0 0 0 0 0
Totale 5.307